Vaccination as a strategy for Chlamydia trachomatis control: a global mathematical modeling analysis

Area of Science:

• Infectious Diseases
• Vaccinology
• Public Health Modeling

Background:

• Chlamydia trachomatis (CT) is a prevalent sexually transmitted infection with significant health and economic consequences.
• Vaccination presents a promising strategy for global control of CT infections.

Purpose of the Study:

• To assess the global impact of a hypothetical Chlamydia trachomatis vaccine.
• To evaluate the influence of vaccine efficacy, duration of protection, and coverage on disease burden reduction.
• To compare the effectiveness of adult catch-up versus adolescent-targeted vaccination strategies.

Main Methods:

• A deterministic, age-structured mathematical model was employed.
• Simulations explored various vaccine efficacy levels against infection acquisition (VE S), protection durations, and coverage scenarios.
• Analysis included both adult catch-up and adolescent-targeted vaccination approaches.

Main Results:

• A vaccine with 50% efficacy, 20-year protection, and 80% coverage by 2040 could avert 717 million CT infections by 2050.
• Significant reductions in CT prevalence (26.2%), incidence rate (32.3%), and new infections (26.5%) were projected for 2050.
• The number needed to vaccinate (NNV) to prevent one infection decreased over time, with lower NNV in younger age groups and high-risk populations.

Conclusions:

• Vaccination against Chlamydia trachomatis offers a viable method to substantially decrease the global infection burden.
• Moderate vaccine efficacy, combined with strategic implementation (adolescent and adult catch-up), can yield significant public health benefits.
• Accelerated vaccine development and integration into public health initiatives are urgently recommended.